Nucleic acid detection is crucial in the clinical practice since it can be used to rapidly identify pathogenic organisms. Rapid detection with highly sensitive methods is essential for diagnosis and choosing treatment courses. This is a complex task since samples need to be enriched with the nucleotide targets and at the same time needs to eliminate nucleases, PCR inhibitors and host material. This means that to detect and identify genetic material from a pathogen, in the form of 18S and 28S rRNA, in an efficient and reliable way, the protocol needs to eliminateeukaryotic rRNA from the sample to avoid competition for the substrates during the cDNA synthesis, since it decreases the detection sensitivity.

